Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albrecht

Showing results (301-310 of 528) with videos related to

Pageof 53
Sort By:
Der Nervenarzt|October 29, 2017
[New aspects of symptomatic MS treatment: Part 5 - fatigue]T Henze, W Feneberg, P Flachenecker, et al.
Der Nervenarzt|October 25, 2017
[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity]T Henze, W Feneberg, P Flachenecker, et al.
Der Nervenarzt|October 25, 2017
[What is new in symptomatic MS treatment: Part 1-introduction and methodical approach, ataxia and tremor]T Henze, W Feneberg, P Flachenecker, et al.
Journal of Patient-Reported Outcomes|January 25, 2023
Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diaryRob Arbuckle, Tim Shea, Kate Burrows, et al.
The Journal of Biological Chemistry|November 26, 2002
Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytesChristopher J Nelsen, David G Rickheim, Melissa M Tucker, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 21, 2009
Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like patternHyunjoo J Lee, Dorothy E Pazin, Ravi S Kahlon, et al.
Radiology|October 1, 1990
Proximal fallopian tube occlusion: diagnosis and treatment with transcervical fallopian tube catheterizationD A Kumpe, S C Zwerdlinger, L J Rothbarth, et al.
Der Nervenarzt|October 29, 2017
[What is new in symptomatic MS treatment: Part 3-bladder dysfunction]T Henze, W Feneberg, P Flachenecker, et al.
Der Nervenarzt|October 29, 2017
[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders]T Henze, W Feneberg, P Flachenecker, et al.
Archives of Dermatology|January 1, 1997
Patchy dermal hypoplasia as a characteristic feature of Proteus syndromeR Happle, P M Steijlen, U Theile, et al.
Pageof 53

Showing results (301-310 of 528) with videos related to

Sort By:
Pageof 53
Der Nervenarzt|October 29, 2017
[New aspects of symptomatic MS treatment: Part 5 - fatigue]T Henze, W Feneberg, P Flachenecker, et al.
Der Nervenarzt|October 25, 2017
[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity]T Henze, W Feneberg, P Flachenecker, et al.
Der Nervenarzt|October 25, 2017
[What is new in symptomatic MS treatment: Part 1-introduction and methodical approach, ataxia and tremor]T Henze, W Feneberg, P Flachenecker, et al.
Journal of Patient-Reported Outcomes|January 25, 2023
Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diaryRob Arbuckle, Tim Shea, Kate Burrows, et al.
The Journal of Biological Chemistry|November 26, 2002
Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytesChristopher J Nelsen, David G Rickheim, Melissa M Tucker, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 21, 2009
Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like patternHyunjoo J Lee, Dorothy E Pazin, Ravi S Kahlon, et al.
Radiology|October 1, 1990
Proximal fallopian tube occlusion: diagnosis and treatment with transcervical fallopian tube catheterizationD A Kumpe, S C Zwerdlinger, L J Rothbarth, et al.
Der Nervenarzt|October 29, 2017
[What is new in symptomatic MS treatment: Part 3-bladder dysfunction]T Henze, W Feneberg, P Flachenecker, et al.
Der Nervenarzt|October 29, 2017
[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders]T Henze, W Feneberg, P Flachenecker, et al.
Archives of Dermatology|January 1, 1997
Patchy dermal hypoplasia as a characteristic feature of Proteus syndromeR Happle, P M Steijlen, U Theile, et al.
Pageof 53